Gedeon Richter raises stake in GZF Polfa
This article was originally published in Scrip
Following its strategy to maintain Poland as its key foreign market and its recent withdrawal from the merger with Polpharma, Gedeon Richter has acquired a further 29.6% state stake in Grodziskie Zaklady Farmaceutyczne Polfa (GZF Polfa) for PLN87.3 million ($43 million), bringing its total holding in the company to 99.8%. Hungary's largest pharmaceutical manufacturer won the Polish Ministry of the Treasury's tender and acquired a 51% ownership in GZF Polfa for $53 million in 2002, with an option for the remainder of the state's shares.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.